Phospho-CDK2 (Thr160) Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5117192-Each-of-1 | In Stock | ₹ 47,392.50 |
PIPA5117192 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 47,392.50
GST (18%): ₹ 8,530.65
Total Price: ₹ 55,923.15
Antigen
Phospho-CDK2 (Thr160)
Classification
Polyclonal
Conjugate
Unconjugated
Gene
CDK2
Gene Alias
A630093N05Rik; CDC28; CDC2A; cdc2-related protein kinase; CDK1; CDK2; CDKN2; Cell division protein kinase 2; cyclin dependent kinase 2; cyclin dependent kinase 2-alpha; cyclin-dependent kinase 2; EC 2.7.11.22; EC 2.7.11.23; kinase Cdc2; MPF; p33 protein kinase; p33(CDK2); p33CDK2; p34 protein kinase
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
1017, 12566, 362817
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
Immunohistochemistry (Paraffin), Western Blot
Concentration
0.29 mg/mL
Formulation
PBS with 50% glycerol and 0.05% ProClin 300; pH 7.3
Gene Accession No.
P24941, P97377, Q63699
Gene Symbols
CDK2
Immunogen
A synthetic phosphorylated peptide around T160 of human CDK2 (NP_0017892?/NP_0012491)
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Positive Samples: HeLa Immunogen sequence: TYTHE CDK2/cyclinO is a member of the cyclin dependent protein kinase family complexed to CyclinO
- CyclinO was used as a specific protein isoform name for the UNG gene which is localized exclusively in the nucleus
- In addition, CyclinO was reported to shows significant uracil-DNA glycosylase activity
- CDK2/cyclinO protein levels increase during G1 phase and the protein is turned over during the course of cell cycle
- The levels of cyclin A-cdk2 is maximal at the G1/S transition and both cdk2 and cyclin A are found associated with DNA in the initiation complex during replication
- Rb protein acts as substrate for cdk2-cyclin E and/or cdk2-cyclin A in vivo
- Cdk2 is activated and specifically localized to the nucleus during late G1-, S-, and G2-phase.